Related Experiment Video
Updated: Jun 4, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Clinico-immunological changes post-immunotherapy with Periplaneta americana
Deepsikha Srivastava1, Shailendra Nath Gaur, Naveen Arora
1Allergy and Immunology Section, Institute of Genomics and Integrative Biology, CSIR, Delhi, India.
European Journal of Clinical Investigation
|February 18, 2011
Summary
Cockroach immunotherapy significantly improved asthma and rhinitis symptoms. Treatment led to favorable immunological changes, including increased IgG4 levels, suggesting a new therapeutic option for allergic diseases.
Area of Science:
- Allergy and Immunology
- Clinical Research
Background:
- Cockroach allergens are common triggers for allergic diseases like asthma and rhinitis.
- Controlled studies are needed to validate cockroach immunotherapy (IT) efficacy.
Purpose of the Study:
- To evaluate the clinical and immunological effects of Periplaneta americana cockroach extract immunotherapy.
- To assess changes in allergic responses after one year of treatment.
Main Methods:
- A 1-year, double-blind, placebo-controlled trial involving 50 patients with asthma, rhinitis, or both.
- Assessed clinical outcomes (symptom/drug scores, airway reactivity) and immunological markers (IgE, IgG1, IgG4, IL-4, IFN-γ) via ELISA and Western blotting.
Main Results:
- Significant clinical improvements were observed in the active IT group compared to placebo.
- Specific IgE levels decreased modestly, while IgG4 levels significantly increased post-immunotherapy.
- Increased IgG4/IgG1 ratio correlated with reduced symptom scores.
Conclusions:
- Cockroach immunotherapy effectively improves clinical and immunological markers in patients with allergic asthma and rhinitis.
- Observed clinical benefits are linked to specific immunological shifts induced by the immunotherapy.
Related Concept Videos
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...